Xilio Therapeutics XLO
NASDAQ XLO
$8.40 -0.14 (-1.64%)
As of: Oct 21, 2026 · 3:59 PM EDT

Xilio Therapeutics (XLO) Share-based Compensation (2020 - 2026)

Updated

Xilio Therapeutics (XLO) recorded Share-based Compensation of $1.6 million in Q2 2026, up 18.3% from $1.35 million a year earlier but down 27.7% from the prior quarter.

Analysis

Xilio Therapeutics (XLO) Share-based Compensation (2020 - 2026) Analysis & Trends

On a TTM basis, Xilio Therapeutics' Share-based Compensation came in at $7.86 million as of Jun 30, 2026, up 31.6% year-over-year; for FY2025, it was $6.94 million, up 7.8% from FY2024.

  • Annual Share-based Compensation has a five-year compound annual growth rate of 39.9% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $6.43 million in FY2024 (-12.8%), $7.38 million in FY2023 (-12.4%), $8.42 million in FY2022 (+69.9%) and $4.96 million in FY2021 (+282.6%).
  • Quarterly Share-based Compensation has ranged from $1.09 million in Q3 2021 to $2.93 million in Q4 2025 over the past five years.
  • On a year-over-year basis, Share-based Compensation has increased for three consecutive quarters, with growth averaging 7.9% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 465.8% in Q4 2021, against a decline of 33.6% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.21 million (Q1 2026), $2.93 million (Q4 2025) and $1.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 166.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 249.00 Mn
10 Xilio Therapeutics 162.81 Mn -364.86 Mn - 1.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Mar 31, 2026 2.21 Mn
Dec 31, 2025 2.93 Mn
Sep 30, 2025 1.12 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.54 Mn
Dec 31, 2024 1.52 Mn
Sep 30, 2024 1.57 Mn
Jun 30, 2024 1.51 Mn
Mar 31, 2024 1.83 Mn
Dec 31, 2023 1.93 Mn
Sep 30, 2023 1.86 Mn
Jun 30, 2023 1.80 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 1.82 Mn
Sep 30, 2022 1.87 Mn
Jun 30, 2022 2.71 Mn
Mar 31, 2022 2.03 Mn
Dec 31, 2021 2.07 Mn
Sep 30, 2021 1.09 Mn
API Access

Xilio Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=XLO&period=max&api_key=YOUR_API_KEY